Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection
- 1 January 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 23 (1), 35-43
- https://doi.org/10.1097/00042560-200001010-00005
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- New-Onset Diabetes Mellitus Associated with Use of Protease InhibitorAnnals of Internal Medicine, 1997
- Severe Diabetes Associated with Protease Inhibitor TherapyAnnals of Internal Medicine, 1997
- Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 1997
- Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapyAIDS, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Protease inhibitor-associated hyperglycaemiaThe Lancet, 1997
- Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatmentsAIDS, 1997
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996